Concepedia

Greg N. Brooke

GN

Statistics

Publications

24

Citations

1.2K

H-Index

18

Active since

2002

Affiliations

Imperial College London(Current)

University of Essex

Hammersmith Hospital

Cancer Research UK

Queen Mary University of London

Greg N. Brooke is an author at Imperial College London specializing in oncology, steroid hormone signaling, and androgen receptor regulation.

Publications per year

2002–2024

24

Publications

24

The Role of Androgen Receptor Mutations in Prostate Cancer Progression

Greg N. Brooke, Charlotte L. Bevan · Current Genomics · 2009 · 180 citations · Full text

Medicine, Endocrinology, Oncology +17

Gliotoxin Is a Dual Inhibitor of Farnesyltransferase and Geranylgeranyltransferase I with Antitumor Activity Against Breast Cancer In Vivo

David M. Vigushin, Niely Mirsaidi, Greg N. Brooke et al. · Medical Oncology · 2004 · 102 citations

Medicine, Oncology, Pharmacology +5

Prohibitin, a protein downregulated by androgens, represses androgen receptor activity

Simon C. Gamble, Deepa Chotai, Michael Odontiadis et al. · Oncogene · 2006 · 93 citations

Life Sciences, Genetics, Molecular Biology +12

The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells

Damien A. Leach, Andrea Mohr, Efstathios S. Giotis et al. · Nature Communications · 2021 · 91 citations · Full text

Medicine, Oncology, Pharmacology +15

Mechanisms of androgen receptor activation in advanced prostate cancer: differential co-activator recruitment and gene expression

Greg N. Brooke, Malcolm G. Parker, Charlotte L. Bevan · Oncogene · 2007 · 79 citations

Life Sciences, Molecular Biology, Oncology +17

1–5 of 24